ClinConnect ClinConnect Logo
Search / Trial NCT06902493

Impact of Prior SGLT2 Inhibitors Use on the Development and Progression of Sepsis-Associated Acute Kidney Injury

Launched by UNIVERSITY OF JAZAN · Mar 28, 2025

Trial Information

Current as of April 29, 2025

Completed

Keywords

Sepsis Acute Kidney Injury Sepsis Associated Acute Kidney Injury Sglt2i

ClinConnect Summary

The primary objective of this study is to investigate whether using SGLT2i may be associated with decreased incidence of sepsis-induced AKI or not.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • All adult (≥ 18 year) patients who were admitted to ICU with sepsis syndromes (sepsis or septic shock), according to sepsis-3 definition.
  • Exclusion Criteria:
  • Missing data
  • Renal transplant or tumor
  • Solitary kidney
  • Established CKD
  • Obstructive uropathy
  • Renal artery stenosis
  • Pregnancy

About University Of Jazan

The University of Jazan is a leading academic institution in Saudi Arabia dedicated to advancing healthcare research and education. With a strong emphasis on clinical trials, the university aims to enhance medical knowledge and improve patient outcomes through innovative studies. The institution fosters collaboration between multidisciplinary teams of researchers, healthcare professionals, and students, ensuring a rigorous and ethical approach to clinical research. By leveraging its state-of-the-art facilities and expertise, the University of Jazan is committed to contributing valuable insights to the global medical community and addressing pressing health challenges.

Locations

Al 'Usaylah, , Saudi Arabia

Patients applied

0 patients applied

Trial Officials

Mohammed Alshrahili, MSc

Principal Investigator

Armed Forces Hospitals, Southern Region, Saudi Arabia

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported